Cincotta L, Foley J W, Cincotta A H
Rowland Institute for Science, Cambridge, MA 02142.
Cancer Res. 1993 Jun 1;53(11):2571-80.
Structural modifications to the photoinactive benzophenoxazine Nile blue A have led to three novel derivatives which include 5-ethylamino-9-diethylaminobenzo[a]phenoxazinium (EtNBA), 5-ethylamino-9-diethylaminobenzo[a]phenothiazinium (EtNBS), and 5-ethylamino-9-diethylaminobenzo[a]phenoselenazinium (EtNBSe) chlorides. The incorporation of sulfur and selenium into the benzophenoxazine moiety results in lipophilic, red-absorbing (650-660 nm) chromophores which possess significantly increased singlet oxygen yields (0.025 and 0.65, respectively, compared to 0.005 for EtNBA). This study examines the photosensitizing efficacies and pharmacokinetics in vitro in the EMT-6 murine mammary sarcoma cell line as well as the physicochemical, photochemical, and redox properties of these new analogues. Comparisons with Photofrin II, the only photosensitizer available clinically, were made in an attempt to high-light their different pharmacological characteristics. The photodynamic activity of the benzophenoxazine dyes correlates with their ability to generate the phototoxin singlet oxygen and increases in the following order: EtNBA < EtNBS << EtNBSe. At an extracellular dye concentration of 0.5 microM, the light dose required to kill approximately 50% of the cells was 2.0 and < 0.5 J/cm2 for the sulfur and selenium dyes, respectively. The light dose required to kill approximately 50% of the cells for both EtNBA and Photofrin II could not be determined because of their weak phototoxic effect under these conditions. At a light dose of 3.3 J/cm2, EtNBSe is approximately 1000 times more phototoxic than Photofrin II. All three benzophenoxazine derivatives are characterized by a similar uptake/efflux pattern in vitro consisting of a rapid and extensive cellular accumulation followed by a slow efflux rate. Contrary to their rapid uptake, 50% of the accumulated EtNBS and EtNBSe is retained intracellularly after a 6-h period in dye-free medium. Video-enhanced fluorescence microscopy corroborates the rapid uptake measurements as well as indicating the intracellular localization of the dyes in both living and thermally inactivated cells. Low extracellular dye concentrations (0.05 microM) result in a punctate fluorescence pattern in the perinuclear region, while higher dye concentrations (> 0.1 microM) lead to additional fluorescence in the cytoplasm, cytomembranes, and other organelles but apparently not the nucleus. Absorption spectrometry revealed that living cells rapidly reduce the dyes to their colorless leuko form (photoinactive) if oxygen is not readily available in the environment. It is shown that the cellular reduction is an enzymatic process and that an oxygen-free and cell-free medium containing both the coenzyme NADH and the hydride transfer enzyme diaphorase is capable of reducing the dyes to the colorless leuko form.(ABSTRACT TRUNCATED AT 400 WORDS)
对光灭活的二苯并吩嗪尼罗蓝A进行结构修饰,得到了三种新型衍生物,包括5-乙氨基-9-二乙氨基苯并[a]吩嗪鎓(EtNBA)、5-乙氨基-9-二乙氨基苯并[a]吩噻嗪鎓(EtNBS)和5-乙氨基-9-二乙氨基苯并[a]吩硒嗪鎓(EtNBSe)氯化物。将硫和硒引入二苯并吩嗪部分,得到了亲脂性的、吸收红光(650 - 660 nm)的发色团,其单线态氧产率显著提高(EtNBS和EtNBSe分别为0.025和0.65,而EtNBA为0.005)。本研究考察了这些新类似物在EMT - 6小鼠乳腺肉瘤细胞系中的体外光敏效力和药代动力学,以及它们的物理化学、光化学和氧化还原性质。与临床上唯一可用的光敏剂Photofrin II进行了比较,以突出它们不同的药理学特性。二苯并吩嗪染料的光动力活性与其产生光毒素单线态氧的能力相关,活性按以下顺序增加:EtNBA < EtNBS << EtNBSe。在细胞外染料浓度为0.5 microM时,杀死约50%细胞所需的光剂量,硫染料和硒染料分别为2.0和< 0.5 J/cm2。由于在这些条件下EtNBA和Photofrin II的光毒性较弱,无法确定杀死约50%细胞所需的光剂量。在光剂量为3.3 J/cm2时,EtNBSe的光毒性比Photofrin II高约1000倍。所有三种二苯并吩嗪衍生物在体外具有相似的摄取/流出模式,即细胞快速大量积累,随后流出速率缓慢。与它们的快速摄取相反,在无染料培养基中培养6小时后,积累的EtNBS和EtNBSe有50%保留在细胞内。视频增强荧光显微镜证实了快速摄取测量结果,并表明染料在活细胞和热灭活细胞中的细胞内定位。低细胞外染料浓度(0.05 microM)导致核周区域出现点状荧光模式,而较高染料浓度(> 0.1 microM)导致细胞质、细胞膜和其他细胞器出现额外荧光,但细胞核显然没有。吸收光谱显示,如果环境中氧气供应不足,活细胞会迅速将染料还原为无色的无色形式(光灭活)。结果表明,细胞还原是一个酶促过程,含有辅酶NADH和氢化物转移酶黄递酶的无氧无细胞培养基能够将染料还原为无色的无色形式。(摘要截断于400字)